Analysts Issue Forecasts for Leidos’ Q1 Earnings (NYSE:LDOS)

Leidos Holdings, Inc. (NYSE:LDOS) – Equities research analysts at Zacks Research raised their Q1 2025 earnings per share (EPS) estimates for shares of Leidos in a report released on Wednesday, December 11th. Zacks Research analyst A. Dutta now expects that the aerospace company will post earnings of $2.35 per share for the quarter, up from their previous forecast of $2.33. The consensus estimate for Leidos’ current full-year earnings is $9.89 per share. Zacks Research also issued estimates for Leidos’ Q2 2025 earnings at $2.54 EPS, Q3 2025 earnings at $2.53 EPS, Q4 2025 earnings at $2.62 EPS, FY2025 earnings at $10.04 EPS, Q2 2026 earnings at $2.76 EPS, Q3 2026 earnings at $2.61 EPS and FY2026 earnings at $10.30 EPS.

A number of other equities analysts have also recently issued reports on LDOS. Wells Fargo & Company cut their target price on shares of Leidos from $230.00 to $205.00 and set an “overweight” rating for the company in a research report on Tuesday, November 26th. Barclays upped their target price on Leidos from $165.00 to $210.00 and gave the company an “overweight” rating in a research note on Monday, November 4th. TD Cowen raised their price target on Leidos from $175.00 to $200.00 and gave the stock a “buy” rating in a research report on Wednesday, October 30th. Citigroup boosted their price target on Leidos from $194.00 to $220.00 and gave the stock a “buy” rating in a report on Wednesday, October 30th. Finally, The Goldman Sachs Group lowered Leidos from a “buy” rating to a “neutral” rating and decreased their price objective for the company from $228.00 to $153.00 in a research note on Thursday. Four analysts have rated the stock with a hold rating, ten have issued a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat.com, Leidos currently has a consensus rating of “Moderate Buy” and a consensus price target of $182.00.

Leidos Price Performance

Leidos stock opened at $153.16 on Friday. The firm has a market capitalization of $20.44 billion, a PE ratio of 17.48, a P/E/G ratio of 1.05 and a beta of 0.64. Leidos has a 52 week low of $105.52 and a 52 week high of $202.90. The firm’s 50-day simple moving average is $171.18 and its 200 day simple moving average is $157.54. The company has a quick ratio of 1.15, a current ratio of 1.23 and a debt-to-equity ratio of 0.87.

Leidos (NYSE:LDOS) last posted its earnings results on Tuesday, October 29th. The aerospace company reported $2.93 EPS for the quarter, topping analysts’ consensus estimates of $1.96 by $0.97. Leidos had a return on equity of 30.31% and a net margin of 7.37%. The company had revenue of $4.19 billion for the quarter, compared to the consensus estimate of $4.06 billion. During the same period in the previous year, the business earned $2.03 earnings per share. Leidos’s quarterly revenue was up 6.9% compared to the same quarter last year.

Hedge Funds Weigh In On Leidos

Several hedge funds and other institutional investors have recently made changes to their positions in LDOS. Ballentine Partners LLC raised its position in Leidos by 3.5% in the third quarter. Ballentine Partners LLC now owns 1,822 shares of the aerospace company’s stock valued at $297,000 after purchasing an additional 62 shares during the period. Key Financial Inc boosted its position in shares of Leidos by 6.5% in the second quarter. Key Financial Inc now owns 1,141 shares of the aerospace company’s stock worth $166,000 after buying an additional 70 shares during the period. Asahi Life Asset Management CO. LTD. grew its stake in shares of Leidos by 3.2% in the third quarter. Asahi Life Asset Management CO. LTD. now owns 2,280 shares of the aerospace company’s stock valued at $372,000 after buying an additional 70 shares in the last quarter. Somerset Trust Co raised its holdings in shares of Leidos by 3.5% during the 3rd quarter. Somerset Trust Co now owns 2,429 shares of the aerospace company’s stock valued at $396,000 after buying an additional 83 shares during the period. Finally, Apella Capital LLC lifted its position in Leidos by 0.8% during the 3rd quarter. Apella Capital LLC now owns 11,366 shares of the aerospace company’s stock worth $1,878,000 after acquiring an additional 89 shares in the last quarter. Institutional investors and hedge funds own 76.12% of the company’s stock.

Insider Activity

In other Leidos news, Director Noel B. Geer purchased 2,000 shares of Leidos stock in a transaction on Wednesday, November 20th. The shares were purchased at an average cost of $161.13 per share, with a total value of $322,260.00. Following the completion of the transaction, the director now directly owns 2,000 shares in the company, valued at approximately $322,260. This represents a ∞ increase in their position. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Robert C. Kovarik, Jr. sold 1,047 shares of the stock in a transaction on Thursday, October 31st. The stock was sold at an average price of $184.94, for a total transaction of $193,632.18. Following the completion of the sale, the director now directly owns 6,408 shares of the company’s stock, valued at $1,185,095.52. The trade was a 14.04 % decrease in their position. The disclosure for this sale can be found here. Corporate insiders own 0.96% of the company’s stock.

Leidos Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Tuesday, December 31st. Shareholders of record on Monday, December 16th will be issued a $0.40 dividend. This represents a $1.60 dividend on an annualized basis and a dividend yield of 1.04%. The ex-dividend date of this dividend is Monday, December 16th. This is a positive change from Leidos’s previous quarterly dividend of $0.38. Leidos’s dividend payout ratio (DPR) is 17.31%.

About Leidos

Leidos Holdings, Inc, together with its subsidiaries, provides services and solutions in the defense, intelligence, civil, and health markets in the United States and internationally. The company operates through Defense Solutions, Civil, and Health segments. The Defense Solutions segment offers national security solutions and systems for air, land, sea, space, and cyberspace for the U.S.